{"id":"https://genegraph.clinicalgenome.org/r/4334150f-ebf0-43b2-98fc-8fa09d0b9b78v1.0","type":"EvidenceStrengthAssertion","dc:description":"Variants in VCAN have been reported in multiple families affected by autosomal dominant Wagner disease since 2005 (Miyamoto et al., PMID 16043844). At least six splicing variants in intron 7 (transcript NM_004385.5) have been reported in humans, often in large families segregating perfectly with the disease. More evidence including additional splicing variants in intron 7 and large deletions involving exon 8 is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. This gene-disease association is further supported by expression studies showing that VCAN is expressed in the eye. In summary, VCAN is definitively associated with autosomal dominant Wagner disease.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/4334150f-ebf0-43b2-98fc-8fa09d0b9b78","GCISnapshot":"https://genegraph.clinicalgenome.org/r/d1ea2623-463f-40f1-befb-5dfde7abc784","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/d1ea2623-463f-40f1-befb-5dfde7abc784_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2021-07-26T18:39:30.252Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/d1ea2623-463f-40f1-befb-5dfde7abc784_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2021-07-26T18:39:19.943Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d1ea2623-463f-40f1-befb-5dfde7abc784_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d1ea2623-463f-40f1-befb-5dfde7abc784_ad_dn_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e3f4c76d-2ad1-42b9-ad19-d5cbd226e527_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Not detected in blood DNA of the proband's parents, and paternity was confirmed with highly polymorphic markers. Same variant reported in PMID: 16636652 and other publications.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/05eeded4-f036-42ea-95ca-e211ef1ac92f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23571384","rdfs:label":"II-1","phenotypeFreeText":"Retinal detachment, cataract, optically empty vitreous with a circumferential avascular preretinal membrane, ectopic macula responsible for exotropia (pseudostrabismus), mild temporal dragging of retinal vessels. Kinetic perimetry showed a constricted peripheral isopter, and full-field electroretinography revealed mild cone-rod dysfunction.","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e3f4c76d-2ad1-42b9-ad19-d5cbd226e527_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23571384","allele":{"id":"https://genegraph.clinicalgenome.org/r/3c9153ca-8aad-4ae0-87a1-f31bd55cf3c5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004385.5(VCAN):c.9265+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA342038"}},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallAutosomalDominantDeNovoVariantEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d1ea2623-463f-40f1-befb-5dfde7abc784_ad_null_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b0b7b223-8da6-4550-8291-9dee22cb1805_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Absent in gnomAD, splicing alteration confirmed in patient fibroblast cells.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b9efff28-1fe6-4cbd-9081-ca98b6487299","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22739342","rdfs:label":"III-13","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b0b7b223-8da6-4550-8291-9dee22cb1805_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22739342","allele":{"id":"https://genegraph.clinicalgenome.org/r/8f71d909-2e29-4e43-ae5c-682a4f8cbeb0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004385.5(VCAN):c.4004-1G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA344474"}},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/ed33c4af-d602-4346-933d-b4b5851fe414_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Absent in gnomAD, found to cause increased V2 & V3 isoform expression in patient blood RNA (Table 4). ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e0e3edff-a7a8-4b15-961a-b1553493f106","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16877430","rdfs:label":"023A","detectionMethod":"Linkage analysis performed using STR markers on the Wagner disease/ERVR locus on chromosome 5. Sanger was performed for the exons and exon-intron junctions for the genes in the minimum region, ie, VCAN and XRCC4.","firstTestingMethod":"Linkage analysis","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ed33c4af-d602-4346-933d-b4b5851fe414_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16877430","allele":{"id":"https://genegraph.clinicalgenome.org/r/be9448a2-ea1a-412f-a6ec-ab09fedb8f16","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004385.5(VCAN):c.4004-5T>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA342037"}},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/c7098b5b-021c-41f1-9a41-b34872477f01_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Absent in gnomAD, splicing alteration shown in patient lymphoblast cells.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f0e9a1c5-6a40-4477-898e-aaf5ddd65329","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21738396","rdfs:label":"V.5","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/c7098b5b-021c-41f1-9a41-b34872477f01_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21738396","allele":{"id":"https://genegraph.clinicalgenome.org/r/6c4fa5dc-fbcd-4640-be9b-e050e699e95b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004385.5(VCAN):c.4004-2A>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA344472"}},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3a8e3a8c-6530-4c80-9f99-8aa8f1c1612a_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Variant absent in gnomAD 2.1, Splicing alteration confirmed in patient blood RNA.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8105dcf2-3d7c-467e-849a-2012d1bd3faa","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16636652","rdfs:label":"49","detectionMethod":"The linkage analysis of this family was described by Brown et al. in  https://pubmed.ncbi.nlm.nih.gov/7748141/, which identified a highly significant linkage (lod score >5.0) between the disease and 10 markers of the chromosome 5q13-q14 region.  Kloeckener-Gruissem et al then used Sanger sequencing to analyze two of the candidate genes in this region, VCAN (aka CSPG2) and EDIL3. A rare variant c.9265+1G>A  in the VCAN gene was found to be segregated with the disease in 21 affected and 26 unaffected individuals.","firstTestingMethod":"Linkage analysis","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/3a8e3a8c-6530-4c80-9f99-8aa8f1c1612a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16636652","allele":{"id":"https://genegraph.clinicalgenome.org/r/3c9153ca-8aad-4ae0-87a1-f31bd55cf3c5"},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/ef1baac4-4970-4e41-a6e2-a2e96db466ed_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Absent in gnomAD, splicing alteration confirmed in patient fibroblast cells.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b3b2d45e-7aa7-4092-b454-849754fc3e7b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22739342","rdfs:label":"IV-3","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ef1baac4-4970-4e41-a6e2-a2e96db466ed_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22739342","allele":{"id":"https://genegraph.clinicalgenome.org/r/7b4bfbf8-e2a1-461c-8d5f-8b3e640f1350","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004385.5(VCAN):c.9265+2T>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA344473"}},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/b5030495-ebc2-46a1-8e69-daaeb8a439da_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Absent in gnomAD, splicing alteration confirmed in patient lymphoblastoid cells.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6eb538ea-7bb7-4b7a-9f80-12a6add13ce5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16043844","rdfs:label":"IV-1","detectionMethod":"Linkage analysis was performed using custom markers on chromosome 5 and 12, previously linked regions to Wagner syndromes (5q13-q14; WGN1 locus and 12q12; COL2A1 gene). A maximum LOD of 3.5 was observed for 5q13-q14 and 12q12 locus was excluded. Sanger sequencing of 10 candidate genes in 5q13-q14 identified a canonical splicing variant c.4004-2A>G in the 11 affected individuals but not in 2 un-affected individuals.","firstTestingMethod":"Linkage analysis","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b5030495-ebc2-46a1-8e69-daaeb8a439da_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16043844","allele":{"id":"https://genegraph.clinicalgenome.org/r/9c1ab1e2-9cbb-4925-82d2-0a4f5091cedb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004385.5(VCAN):c.4004-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA341462"}},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantNullVariantEvidenceCriteria","strengthScore":9},{"id":"https://genegraph.clinicalgenome.org/r/d1ea2623-463f-40f1-befb-5dfde7abc784_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/99cf0255-104c-4502-9ccd-0fbc2992f11a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22739342","rdfs:label":"BC","family":{"id":"https://genegraph.clinicalgenome.org/r/99cf0255-104c-4502-9ccd-0fbc2992f11a","type":"Family","rdfs:label":"BC","member":{"id":"https://genegraph.clinicalgenome.org/r/b3b2d45e-7aa7-4092-b454-849754fc3e7b"}},"phenotypePositiveAllelePositive":3,"phenotypes":"obo:HP_0030673","proband":{"id":"https://genegraph.clinicalgenome.org/r/b3b2d45e-7aa7-4092-b454-849754fc3e7b"}},{"id":"https://genegraph.clinicalgenome.org/r/417c700e-8d86-411c-971b-9ad14ad4bb74_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23571384","rdfs:label":"DeNovo","family":{"id":"https://genegraph.clinicalgenome.org/r/417c700e-8d86-411c-971b-9ad14ad4bb74","type":"Family","rdfs:label":"DeNovo","member":{"id":"https://genegraph.clinicalgenome.org/r/05eeded4-f036-42ea-95ca-e211ef1ac92f"}},"phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0030673","proband":{"id":"https://genegraph.clinicalgenome.org/r/05eeded4-f036-42ea-95ca-e211ef1ac92f"}},{"id":"https://genegraph.clinicalgenome.org/r/26c3dbe5-cae5-4ffe-8a65-a7ea8c35acea_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21738396","rdfs:label":"French Wagner 2","estimatedLodScore":3.91,"family":{"id":"https://genegraph.clinicalgenome.org/r/26c3dbe5-cae5-4ffe-8a65-a7ea8c35acea","type":"Family","rdfs:label":"French Wagner 2","member":{"id":"https://genegraph.clinicalgenome.org/r/f0e9a1c5-6a40-4477-898e-aaf5ddd65329"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"familial exudative vitreoretinopathy","phenotypePositiveAllelePositive":10,"phenotypes":"obo:HP_0030673","proband":{"id":"https://genegraph.clinicalgenome.org/r/f0e9a1c5-6a40-4477-898e-aaf5ddd65329"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/15d81784-b449-4ca4-8438-d1804eb4cf3c_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16636652","rdfs:label":"Swiss Wagner family","estimatedLodScore":12.64,"family":{"id":"https://genegraph.clinicalgenome.org/r/15d81784-b449-4ca4-8438-d1804eb4cf3c","type":"Family","rdfs:label":"Swiss Wagner family","member":{"id":"https://genegraph.clinicalgenome.org/r/8105dcf2-3d7c-467e-849a-2012d1bd3faa"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Wagner vitreoretinopathy, an 'empty' vitreous cavity with fibrillary condensation or avascular strands and veils. Additional features include chorioretinal atrophy with loss of the retinal pigment epithelium (RPE), lattice degeneration of the retina, complicated cataracts, mild myopia, and peripheral traction retinal detachment.","phenotypePositiveAllelePositive":21,"proband":{"id":"https://genegraph.clinicalgenome.org/r/8105dcf2-3d7c-467e-849a-2012d1bd3faa"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/274f9606-d370-4ec0-8e8d-1ce13d19cedb_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22739342","rdfs:label":"FL","estimatedLodScore":6.92,"family":{"id":"https://genegraph.clinicalgenome.org/r/274f9606-d370-4ec0-8e8d-1ce13d19cedb","type":"Family","rdfs:label":"FL","member":{"id":"https://genegraph.clinicalgenome.org/r/b9efff28-1fe6-4cbd-9081-ca98b6487299"}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":19,"phenotypes":"obo:HP_0030673","proband":{"id":"https://genegraph.clinicalgenome.org/r/b9efff28-1fe6-4cbd-9081-ca98b6487299"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/0e8f4c30-3567-4c36-9da1-d7e1eaf20f85_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16043844","rdfs:label":"Tokushima pedigree","family":{"id":"https://genegraph.clinicalgenome.org/r/0e8f4c30-3567-4c36-9da1-d7e1eaf20f85","type":"Family","rdfs:label":"Tokushima pedigree","member":{"id":"https://genegraph.clinicalgenome.org/r/6eb538ea-7bb7-4b7a-9f80-12a6add13ce5"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Ocular phenotypes included an empty vitreous with fibrillary condensations in the vitreous cavity, avascular membrane (stands and veils), perivascular sheathing or obliteration, and progressive chorioretinal dystrophy with pigmentation. ","phenotypePositiveAllelePositive":11,"phenotypes":"obo:HP_0030673","proband":{"id":"https://genegraph.clinicalgenome.org/r/6eb538ea-7bb7-4b7a-9f80-12a6add13ce5"},"publishedLodScore":3.48,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/b79934cf-7feb-456c-85a7-73fdb0970c6b_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16877430","rdfs:label":"W95-023","estimatedLodScore":7.83,"family":{"id":"https://genegraph.clinicalgenome.org/r/b79934cf-7feb-456c-85a7-73fdb0970c6b","type":"Family","rdfs:label":"W95-023","member":{"id":"https://genegraph.clinicalgenome.org/r/e0e3edff-a7a8-4b15-961a-b1553493f106"}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":16,"proband":{"id":"https://genegraph.clinicalgenome.org/r/e0e3edff-a7a8-4b15-961a-b1553493f106"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/d1ea2623-463f-40f1-befb-5dfde7abc784_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d1ea2623-463f-40f1-befb-5dfde7abc784_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/535f06d4-2416-4a24-9e23-bbb0d55049bb","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b9786cc8-f56d-4584-a571-1668d61b6450","type":"Finding","dc:description":"RT-qPCR showing four VCAN isoforms using cell culture of human trabecular meshwork, human ciliary muscle and its culture.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16110303","rdfs:label":"RT-qPCR","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3afb89f5-9fe9-4d1f-9ada-9dcecfb1009f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6d5ee0ec-600d-42ae-86bb-43da86e38f1e","type":"Finding","dc:description":"Alpha & beta versican expressed in rat retina starting at embryonic day 13. By postnatal day 0 (P0), beta-versican staining  is  largely  confined  to  the  inner  plexiform  layer, whereas alpha-versican is also apparent in the neuroblast layer. At P9, versican staining is most intense in the inner and outer plexiform and ganglion cell layers, accompanied by diffuse staining in the inner and outer nuclear layers.  In adult rat, alpha-versican immunoreactivity is seen in the retina and optic nerve,  whereas beta-versican has essentially disappeared from the adult retina and is present only in the laminar beams of the optic nerve.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15336497","rdfs:label":"IHC staining of versican in rat retina","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0.5}],"evidenceStrength":"Definitive","sequence":3149,"specifiedBy":"GeneValidityCriteria8","strengthScore":12.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/ZdN6Fo01O_s","type":"GeneValidityProposition","disease":"obo:MONDO_0007740","gene":"hgnc:2464","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_d1ea2623-463f-40f1-befb-5dfde7abc784-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}